Stock listing
Polypid Ltd.
Selected listing: PYPD · NASDAQ · USD · US
Polypid Ltd. (NASDAQ:PYPD), Health Technology. Latest release Oct 1, 2026: European Medicines Agency Validates PolyPid’s Marketing Authorization Application…
- Ticker
- NASDAQ:PYPD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Polypid Ltd.
Polypid Ltd. is a public company traded under the ticker PYPD in the American market. Polypid focuses on developing innovative drug delivery systems to improve patient outcomes.
Latest news from Polypid Ltd.
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
October 1, 2026
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
September 30, 2026
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
September 30, 2026
PolyPid Announces Participation in Upcoming Fall Investor Conferences
September 15, 2026
PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 12, 2026